U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Cor pulmonale

MedGen UID:
18765
Concept ID:
C0034072
Disease or Syndrome
Synonyms: Cor Pulmonale; Disease, Pulmonary Heart; Diseases, Pulmonary Heart; Heart Disease, Pulmonary; Heart Diseases, Pulmonary; Pulmonary Heart Disease; Pulmonary Heart Diseases
SNOMED CT: Cor pulmonale (83291003); Pulmonary heart disease (83291003); Right heart failure due to pulmonary hypertension (83291003)
 
HPO: HP:0001648
Monarch Initiative: MONDO:0004596

Definition

Right-sided heart failure resulting from chronic hypertension in the pulmonary arteries and right ventricle. [from HPO]

Conditions with this feature

Cystic fibrosis
MedGen UID:
41393
Concept ID:
C0010674
Disease or Syndrome
Cystic fibrosis (CF) is a multisystem disease affecting epithelia of the respiratory tract, exocrine pancreas, intestine, hepatobiliary system, and exocrine sweat glands. Morbidities include recurrent sinusitis and bronchitis, progressive obstructive pulmonary disease with bronchiectasis, exocrine pancreatic deficiency and malnutrition, pancreatitis, gastrointestinal manifestations (meconium ileus, rectal prolapse, distal intestinal obstructive syndrome), liver disease, diabetes, male infertility due to hypoplasia or aplasia of the vas deferens, and reduced fertility or infertility in some women. Pulmonary disease is the major cause of morbidity and mortality in CF.
Isolated Pierre-Robin syndrome
MedGen UID:
19310
Concept ID:
C0031900
Congenital Abnormality
Pierre Robin sequence is a craniofacial anomaly comprising mandibular hypoplasia, cleft secondary palate, and glossoptosis leading to life-threatening obstructive apnea and feeding difficulties during the neonatal period (summary by Tan et al., 2013).
X-linked agammaglobulinemia
MedGen UID:
65123
Concept ID:
C0221026
Disease or Syndrome
X-linked agammaglobulinemia (XLA) is characterized by recurrent bacterial infections in affected males in the first two years of life. Recurrent otitis is the most common infection prior to diagnosis. Conjunctivitis, sinopulmonary infections, diarrhea, and skin infections are also frequently seen. Approximately 60% of individuals with XLA are recognized as having immunodeficiency when they develop a severe, life-threatening infection such as pneumonia, empyema, meningitis, sepsis, cellulitis, or septic arthritis. S pneumoniae and H influenzae are the most common organisms found prior to diagnosis and may continue to cause sinusitis and otitis after diagnosis and the initiation of gammaglobulin substitution therapy. Severe, difficult-to-treat enteroviral infections (often manifest as dermatomyositis or chronic meningoencephalitis) can be prevented by this treatment. The prognosis for individuals with XLA has improved markedly in the last 25 years as a result of earlier diagnosis, the development of preparations of gammaglobulin that allow normal concentrations of serum IgG to be achieved, and more liberal use of antibiotics.
Desquamative interstitial pneumonia
MedGen UID:
65962
Concept ID:
C0238378
Disease or Syndrome
Interstitial lung disease (ILD), or pneumonitis, is a heterogeneous group of disorders characterized pathologically by expansion of the interstitial compartment of the lung by inflammatory cells. Fibrosis occurs in many cases (Visscher and Myers, 2006). See also interstitial lung disease-1 (ILD1; 619611). Desquamative interstitial pneumonitis (DIP) was originally described as a pathologic entity by Liebow et al. (1965). Lung biopsy shows diffuse and uniform filling of alveoli by clusters of cells which Liebow et al. (1965) speculated to be 'desquamated pneumocytes.' Since then, these cells have been shown primarily to be pigmented alveolar macrophages. Other features include thickened alveolar septa with an infiltrate of inflammatory cells and plump, cuboidal type II pneumocytes. Mild collagen deposition without architectural distortion or honeycombing may be present. Different forms of ILD represent pathologic classifications based on histologic patterns rather than clinical diagnoses and may occur in a variety of clinical contexts (Visscher and Myers, 2006). Although DIP occurs most often as a sporadic disorder in adults during the third to fifth decade of life and is highly associated with smoking (Carrington et al., 1978), reports of a familial form with onset in infancy and early death suggest a genetic basis (Sharief et al., 1994). Cases of DIP reported in infants are often more severe and refractory to treatment than those reported in adults (Nogee et al., 2001).
Lymphoid interstitial pneumonia
MedGen UID:
82682
Concept ID:
C0264511
Disease or Syndrome
Lymphocytic interstitial pneumonitis is a benign lymphoproliferative disorder of the lung that is characterized by the presence of a dense, predominantly lymphocytic interstitial infiltrate (lymphocytes, plasma cells, other elements of the lymphoreticular system) that expands the alveolar septa.
Hereditary mucoepithelial dysplasia
MedGen UID:
220887
Concept ID:
C1274795
Congenital Abnormality
Hereditary mucoepithelial dysplasia (HMD) is a rare autosomal dominant genodermatosis characterized by onset in infancy of a panepithelial defect involving the oral, nasal, conjunctival, vaginal, cervical, perineal, urethral, and bladder mucosa. Patients develop cataracts, blindness, nonscarring alopecia, perineal psoriasiform lesions, and follicular keratoses (Witkop et al., 1982). Although 1 family was reported to have progressive severe interstitial lung disease (Witkop et al., 1979), this feature has not been reported in other families and is not considered a criterion for diagnosis. However, the clinical triad of nonscarring alopecia, well-demarcated fiery red mucosa, and psoriasiform perineal involvement has been consistently observed (review by Boralevi et al., 2005).
Chondroitin-6-sulfaturia, defective cellular immunity, nephrotic syndrome
MedGen UID:
349095
Concept ID:
C1859104
Disease or Syndrome
Frontometaphyseal dysplasia 1
MedGen UID:
923943
Concept ID:
C4281559
Congenital Abnormality
The X-linked otopalatodigital (X-OPD) spectrum disorders, characterized primarily by skeletal dysplasia, include the following: Otopalatodigital syndrome type 1 (OPD1). Otopalatodigital syndrome type 2 (OPD2). Frontometaphyseal dysplasia type 1 (FMD1). Melnick-Needles syndrome (MNS). Terminal osseous dysplasia with pigmentary skin defects (TODPD). In OPD1, most manifestations are present at birth; females can present with severity similar to affected males, although some have only mild manifestations. In OPD2, females are less severely affected than related affected males. Most males with OPD2 die during the first year of life, usually from thoracic hypoplasia resulting in pulmonary insufficiency. Males who live beyond the first year of life are usually developmentally delayed and require respiratory support and assistance with feeding. In FMD1, females are less severely affected than related affected males. Males do not experience a progressive skeletal dysplasia but may have joint contractures and hand and foot malformations. Progressive scoliosis is observed in both affected males and females. In MNS, wide phenotypic variability is observed; some individuals are diagnosed in adulthood, while others require respiratory support and have reduced longevity. MNS in males results in perinatal lethality in all recorded cases. TODPD, seen only in females, is characterized by a skeletal dysplasia that is most prominent in the digits, pigmentary defects of the skin, and recurrent digital fibromata.

Professional guidelines

PubMed

Arrigo M, Price S, Harjola VP, Huber LC, Schaubroeck HAI, Vieillard-Baron A, Mebazaa A, Masip J
Eur Heart J Acute Cardiovasc Care 2024 Mar 11;13(3):304-312. doi: 10.1093/ehjacc/zuad157. PMID: 38135288Free PMC Article
Grotberg JC, Reynolds D, Kraft BD
Crit Care 2023 Jul 18;27(1):289. doi: 10.1186/s13054-023-04572-w. PMID: 37464381Free PMC Article
Bettoncelli G, Blasi F, Brusasco V, Centanni S, Corrado A, De Benedetto F, De Michele F, Di Maria GU, Donner CF, Falcone F, Mereu C, Nardini S, Pasqua F, Polverino M, Rossi A, Sanguinetti CM
Sarcoidosis Vasc Diffuse Lung Dis 2014 May 12;31 Suppl 1:3-21. PMID: 24820963

Recent clinical studies

Etiology

Arrigo M, Price S, Harjola VP, Huber LC, Schaubroeck HAI, Vieillard-Baron A, Mebazaa A, Masip J
Eur Heart J Acute Cardiovasc Care 2024 Mar 11;13(3):304-312. doi: 10.1093/ehjacc/zuad157. PMID: 38135288Free PMC Article
Alerhand S, Adrian RJ
Am J Emerg Med 2023 Oct;72:72-84. Epub 2023 Jul 10 doi: 10.1016/j.ajem.2023.07.011. PMID: 37499553
Grotberg JC, Reynolds D, Kraft BD
Crit Care 2023 Jul 18;27(1):289. doi: 10.1186/s13054-023-04572-w. PMID: 37464381Free PMC Article
Ahmad K, Khangoora V, Nathan SD
Cardiol Clin 2022 Feb;40(1):77-88. doi: 10.1016/j.ccl.2021.08.005. PMID: 34809919
Valeyre D, Bernaudin JF, Jeny F, Duchemann B, Freynet O, Planès C, Kambouchner M, Nunes H
Clin Chest Med 2015 Dec;36(4):631-41. doi: 10.1016/j.ccm.2015.08.006. PMID: 26593138

Diagnosis

Arrigo M, Price S, Harjola VP, Huber LC, Schaubroeck HAI, Vieillard-Baron A, Mebazaa A, Masip J
Eur Heart J Acute Cardiovasc Care 2024 Mar 11;13(3):304-312. doi: 10.1093/ehjacc/zuad157. PMID: 38135288Free PMC Article
Ahmad K, Khangoora V, Nathan SD
Cardiol Clin 2022 Feb;40(1):77-88. doi: 10.1016/j.ccl.2021.08.005. PMID: 34809919
Pinsky MR
Crit Care 2016 Sep 10;20(1):266. doi: 10.1186/s13054-016-1440-0. PMID: 27613549Free PMC Article
Valeyre D, Bernaudin JF, Jeny F, Duchemann B, Freynet O, Planès C, Kambouchner M, Nunes H
Clin Chest Med 2015 Dec;36(4):631-41. doi: 10.1016/j.ccm.2015.08.006. PMID: 26593138
Qureshi A
Semin Respir Crit Care Med 2009 Jun;30(3):315-20. Epub 2009 May 18 doi: 10.1055/s-0029-1222445. PMID: 19452391

Therapy

Fu C, Wang L, Cai W
Front Immunol 2024;15:1452849. Epub 2024 Aug 20 doi: 10.3389/fimmu.2024.1452849. PMID: 39229261Free PMC Article
Liu X, Jiao X, Gong X, Nie Q, Li Y, Zhen G, Cheng M, He J, Yuan Y, Yang Y
Int J Chron Obstruct Pulmon Dis 2023;18:907-917. Epub 2023 May 18 doi: 10.2147/COPD.S410954. PMID: 37223656Free PMC Article
Alajaji W, Baydoun A, Al-Kindi SG, Henry L, Hanna MA, Oliveira GH
Int J Cardiol 2016 Nov 15;223:320-324. Epub 2016 Aug 4 doi: 10.1016/j.ijcard.2016.08.018. PMID: 27543702
Marchiori E, Lourenço S, Gasparetto TD, Zanetti G, Mano CM, Nobre LF
Lung 2010 Apr;188(2):165-71. Epub 2010 Feb 13 doi: 10.1007/s00408-010-9230-y. PMID: 20155272
Lancet 1981 Mar 28;1(8222):681-6. PMID: 6110912

Prognosis

Arrigo M, Price S, Harjola VP, Huber LC, Schaubroeck HAI, Vieillard-Baron A, Mebazaa A, Masip J
Eur Heart J Acute Cardiovasc Care 2024 Mar 11;13(3):304-312. doi: 10.1093/ehjacc/zuad157. PMID: 38135288Free PMC Article
Liu X, Jiao X, Gong X, Nie Q, Li Y, Zhen G, Cheng M, He J, Yuan Y, Yang Y
Int J Chron Obstruct Pulmon Dis 2023;18:907-917. Epub 2023 May 18 doi: 10.2147/COPD.S410954. PMID: 37223656Free PMC Article
Weitzenblum E, Chaouat A
Chron Respir Dis 2009;6(3):177-85. doi: 10.1177/1479972309104664. PMID: 19643833
Qureshi A
Semin Respir Crit Care Med 2009 Jun;30(3):315-20. Epub 2009 May 18 doi: 10.1055/s-0029-1222445. PMID: 19452391
Pinsky MR
Curr Opin Crit Care 2007 Oct;13(5):528-31. doi: 10.1097/MCC.0b013e3282efad97. PMID: 17762231

Clinical prediction guides

Nunes MC, Guimarães Júnior MH, Diamantino AC, Gelape CL, Ferrari TC
Heart 2017 May;103(9):651-658. Epub 2017 Mar 11 doi: 10.1136/heartjnl-2016-309870. PMID: 28285268
Marchiori E, Lourenço S, Gasparetto TD, Zanetti G, Mano CM, Nobre LF
Lung 2010 Apr;188(2):165-71. Epub 2010 Feb 13 doi: 10.1007/s00408-010-9230-y. PMID: 20155272
Jardin F, Vieillard-Baron A
Curr Opin Crit Care 2009 Feb;15(1):67-70. doi: 10.1097/mcc.0b013e3283220ddd. PMID: 19186411
Pinsky MR
Curr Opin Crit Care 2007 Oct;13(5):528-31. doi: 10.1097/MCC.0b013e3282efad97. PMID: 17762231
Lancet 1981 Mar 28;1(8222):681-6. PMID: 6110912

Recent systematic reviews

Ajam M, Drake M, Ran R, Mukundan S, Masri A, Rahmouni H
Echocardiography 2022 Feb;39(2):330-338. Epub 2022 Jan 18 doi: 10.1111/echo.15294. PMID: 35043474
Alajaji W, Baydoun A, Al-Kindi SG, Henry L, Hanna MA, Oliveira GH
Int J Cardiol 2016 Nov 15;223:320-324. Epub 2016 Aug 4 doi: 10.1016/j.ijcard.2016.08.018. PMID: 27543702
Shi L, Xie Y, Liao X, Chai Y, Luo Y
BMC Complement Altern Med 2015 Nov 24;15:418. doi: 10.1186/s12906-015-0939-2. PMID: 26603978Free PMC Article
Kawaguchi A, Isayama T, Mori R, Minami H, Yang Y, Tamura M
Cochrane Database Syst Rev 2013 Feb 28;2013(2):CD009449. doi: 10.1002/14651858.CD009449.pub2. PMID: 23450605Free PMC Article
Liu C, Chen J
Cochrane Database Syst Rev 2006 Jul 19;(3):CD004434. doi: 10.1002/14651858.CD004434.pub3. PMID: 16856046

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...